Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEurocell Regulatory News (ECEL)

Share Price Information for Eurocell (ECEL)

Share Price is delayed by 15 minutes
Get Live Data
110.50    1.50 (1.38%)
Bid:
106.50
Ask:
110.00
Spread: 3.50 (3.286%)
Market Cap: £108.90m
ECEL Live PriceLast checked at - London Stock Exchange

Intraday Eurocell Share Chart

Trading Update

14 May 2026 07:00

RNS Number : 2218E
Eurocell plc
14 May 2026
 

14 May 2026

EUROCELL PLC

("Eurocell" the "Group" or the "Company")

Trading Update

 

Eurocell plc, the leading UK manufacturer and distributor of window and door products to the trade, provides the following update for the first four months of 2026, in advance of the Annual General Meeting ("AGM") later today.

 

Summary

Trading conditions have remained subdued in 2026. Ongoing challenging macroeconomic conditions and weak consumer confidence have been compounded by uncertainty over the impact of conflict in the Middle East on demand and supply chains. This has continued to affect activity levels in both the repair, maintenance and improvement (RMI) market and new build housing.

 

To mitigate the impact of weak markets and the situation in the Middle East, we continue to invest in and progress our strategic initiatives, implement operational improvements, focus on cost control and offset the impact of higher input cost prices through a combination of surcharges and sales strategies.

 

However, the effect of this backdrop on consumer confidence and new build housing market activity over the near term remains difficult to assess, which is reflected in the range of analysts' forecasts for the year(1).

 

(1) Company compiled range of analysts' forecast adjusted profit before tax for the year of £21 million to £23 million.

 

Trading Performance

Group sales for the four months to 30 April 2026 were up 9%(2) on 2025. Excluding Alunet, sales were up 1%(2), with an improvement to +5%(2) for the month of April. Comparisons by division for the four-month period were:

 

Sales to 30 April 2026

vs 2025(2)

Profiles Division

-4%

Branch Network Division

+5%

Group, excluding Alunet

+1%

Total Group, including Alunet

+9%

(2) On a trading day adjusted basis

 

Profiles - sales down 4%, reflecting reduced RMI activity through our trade fabricators, and persistent wet weather in the first quarter, with new build and social housing fabricators reporting a lack of call-off activity from their customers.

 

Branch Network - sales up 5%, reflecting:

· Underlying Branch Network sales to the RMI market down 3%

· Offset by the benefits of progress with our strategic initiatives for window and door sales (up 29%), e-commerce activity (up 40%), and garden rooms (up 6%)

· The nine new branches opened since the end of 2024 have delivered incremental sales of £1.1 million so far in 2026, compared to the corresponding period in 2025

 

New branches create a short-term drag on profitability but enable longer-term profit improvement. Whilst we have identified further potential new sites, we have temporarily paused the opening programme until there is better visibility over the general economic outlook.

 

Alunet (acquired in March 2025) - continues to perform strongly, driven by market share gains.

 

Alunet sales were £18.6 million for the 4 months to 30 April 2026, compared to £8.3 million for the 2-month post-acquisition period to 30 April 2025. On a calendar basis, Alunet sales for the 4 months to 30 April 2026 were 19% ahead of the corresponding period in 2025, reflecting:

· Alunet Systems new business with fourteen Eurocell fabricators, plus launch of the new Aluna+ aluminium window system 

· Comp Door continuing to acquire new installers, plus impact of the new Sleekskin door and benefits from cross selling opportunities through the Branch Network

 

As a result of Alunet's strong EBITDA delivery, we expect to make earnout payments shortly of c.£4 million in respect of its 2025 performance.

 

Capital Allocation

In line with our strategic plan, further investments in the next 12 months include delivering the project to modernise our IT infrastructure, where we expect to transition at the end of 2026.

 

We are committed to driving shareholder returns through a combination of ordinary dividends and supplementary distributions where appropriate. Total shareholder returns for 2025 were £11.4 million, equivalent to a yield of c.8%. This follows total returns for 2024 of £21.2 million, equivalent to a yield of c.14%.

 

As previously announced, our intention remains to continue share buybacks in due course, assuming no prolonged impact from the situation in the Middle East and subject to maintaining a strong financial position.

 

Our balance sheet is strong, and we have good headroom on our debt facility, which was renewed in March 2026.

 

 

Enquiries:

Eurocell plc

Will Truman, Chief Executive Officer +44 (0) 1773 842 105

Michael Scott, Chief Financial Officer +44 (0) 1773 842 140

Teneo

Nick de Bunsen +44 (0) 7825 575 258

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBUGDUUSBDGLX
Date   Source Headline
28th Nov 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20257:00 amRNSTransaction in Own Shares
25th Nov 20257:00 amRNSTransaction in Own Shares
24th Nov 20257:00 amRNSTransaction in Own Shares
21st Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20257:00 amRNSTransaction in Own Shares
18th Nov 20257:00 amRNSTransaction in Own Shares
17th Nov 20257:00 amRNSTransaction in Own Shares
14th Nov 20257:00 amRNSTransaction in Own Shares
13th Nov 20257:00 amRNSTransaction in Own Shares
12th Nov 20257:00 amRNSTransaction in Own Shares
11th Nov 20257:00 amRNSDirector/PDMR Shareholding
11th Nov 20257:00 amRNSTransaction in Own Shares
10th Nov 20259:30 amRNSDirector/PDMR Shareholding
10th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSDirectorate change
4th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSTransaction in Own Shares
27th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20257:00 amRNSTransaction in Own Shares
23rd Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 20257:00 amRNSTransaction in Own Shares
21st Oct 20257:00 amRNSTransaction in Own Shares
20th Oct 20257:00 amRNSTransaction in Own Shares
17th Oct 20257:00 amRNSTransaction in Own Shares
16th Oct 20257:00 amRNSTransaction in Own Shares
15th Oct 20257:00 amRNSTransaction in Own Shares
14th Oct 20257:00 amRNSTransaction in Own Shares
13th Oct 20257:00 amRNSTransaction in Own Shares
10th Oct 20257:00 amRNSTransaction in Own Shares
9th Oct 20257:00 amRNSTransaction in Own Shares
8th Oct 20257:00 amRNSTransaction in Own Shares
7th Oct 20257:00 amRNSTransaction in Own Shares
6th Oct 20257:00 amRNSTransaction in Own Shares
3rd Oct 20257:00 amRNSTransaction in Own Shares
2nd Oct 20257:00 amRNSTransaction in Own Shares
1st Oct 20257:00 amRNSTransaction in Own Shares
30th Sep 20257:00 amRNSTransaction in Own Shares
29th Sep 20257:00 amRNSTransaction in Own Shares
26th Sep 20257:00 amRNSTransaction in Own Shares
25th Sep 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.